PULS's board consists of extensive scientific, industrial, business, legal and financial experience and expertise.

Pontus Ottosson - CEO

M.Sc. from Chalmers School of Entrepreneurship and Lieutenant in the Army reserve. Ottosson is CEO of P.U.L.S. AB since its operative start in 2003. Besides from being CEO of PULS, Ottosson is board member of AcuCort AB.

Mats Ardevall - CFO

M.Sc. Industrial Engineering and Management. He has since 1984 worked in the pharma and POC diagnostic industry in various positions within Finance, most recently as CFO/Director of Finance of HemoCue.

Björn Dellgren - Business Development

M.Sc.(BA). Former Partner at BankInvest, Denmark and have worked with international biotech venture investments and fund management since 2000. Previous Director of Business Development at Pharmacia and various international positions in sales, marketing and business management at Pharmacia and the American pharmaceutical company, Lederle. Currently board member of Cernelle AB, Sweden, previous board member of Cellectis SA, France and CMC Biologics, Denmark. Project leader of Adenovir Pharma AB.

Carina Eldh - Finance & Administration

Financial and administrative support for PULS and its portfolio companies since 2011. Accountant with 20 years of experience in accounting, auditing and taxation matters. Previous positions at KPMG and other accounting firms, the Swedish Tax Agency and Öresundskraft.

Jeanette Robertsson - Pharmaceutical Development & Quality

PhD, M.Sc. in Pharmacy, followed by Post-doc at Georgetown University, Washington D.C. and University of Pittsburgh, Pittsburgh, Pennsylvania, resulting in 20 publications in peer-reviewed scientific journals. She has since 1991 worked within the pharma industry with international responsibility as Medical Director with close collaboration with regulatory affairs, international marketing and pre-clinical departments, as Project Manager of drug development projects, and as Director of Clinical Trial Management, with international overall responsibility of clinical trials, regulatory affairs and drug safety. She has held positions at Novartis, Perstorp Pharma, Searle Scandinavia, Tigran Technologies and CDC. Project leader of Laccure AB and board member of Glactone Pharma AB.